Burkina Faso vs Laos: Share of pregnant women with HIV that receive antiretroviral therapy
Burkina Faso
69.0%
in 2024
Laos
68.0%
in 2024
Burkina Faso rank
52nd
Laos rank
54th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Burkina Faso
- Laos
How they compare
Burkina Faso currently reports 69.0% against 68.0% in Laos, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Laos ahead.
Burkina Faso ranks 52nd and Laos ranks 54th of 84 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 4.2% | 5.8% | Burkina Faso |
| 2010s | 51.5% | 20.2% | 31.3% | Burkina Faso |
| 2020s | 79.8% | 44.8% | 35.0% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Burkina Faso or Laos?
- Burkina Faso, at 69.0% against 68.0% in Laos as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Burkina Faso and Laos?
- 1.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Laos?
- 25 years are reported by both, from 2000 to 2024.
- How do Burkina Faso and Laos rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Burkina Faso ranks 52nd and Laos ranks 54th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.